Background Whether respiratory muscle training is of benefit to patients with chronic airflow limitation is controversial. The objective of the study was to determine the effect of resistance breathing training on physiological and functional measures in patients with chronic airflow obstruction. Methods The design was a randomised, double blind, controlled trial with a six month follow up. Eighty two patients with a forced expiratory volume in one second (FEVI) of less than 70% predicted, and an FEV,Ivital capacity ratio of less than 0 7, were randomised to receive training for 10 minutes five times daily with progressively larger resistances through a resistive breathing device (PFLEX) as tolerated or to a sham device which gave minimal resistance. The main outcome measures, respiratory muscle strength and endurance, a progressive exercise test, a six minute walk test and physical and emotional function (chronic respiratory questionnaire) were assessed at monthly intervals. Patients in both groups were also randomised to wear or not wear nose clips during their training.
Abstract
Background Whether respiratory muscle training is of benefit to patients with chronic airflow limitation is controversial. The objective of the study was to determine the effect of resistance breathing training on physiological and functional measures in patients with chronic airflow obstruction. Methods The design was a randomised, double blind, controlled trial with a six month follow up. Eighty two patients with a forced expiratory volume in one second (FEVI) of less than 70% predicted, and an FEV,Ivital capacity ratio of less than 0 7, were randomised to receive training for 10 minutes five times daily with progressively larger resistances through a resistive breathing device (PFLEX) as tolerated or to a sham device which gave minimal resistance. The main outcome measures, respiratory muscle strength and endurance, a progressive exercise test, a six minute walk test and physical and emotional function (chronic respiratory questionnaire) were assessed at monthly intervals. Patients in both groups were also randomised to wear or not wear nose clips during their training. Results No significant differences were observed between treatment and control groups, with or without nose clips, for any of the outcomes. Confidence intervals on the difference between treatments were narrow, excluding clinically important difference in any major outcome. Conclusion This training regimen fails to strengthen respiratory muscles or improve exercise or functional capacity in patients with chronic airflow limitation.
It has been suggested that strengthening the respiratory muscles in patients with chronic airflow limitation may reduce the discomfort of daily activities and increase functional capacity.;Some studies have reported improved respiratory muscle strength and endurance,' 2 improved exercise capacity,34 and improved functional capacity and reduced dyspnoea in day to day life following respiratory muscle training.56 These studies have been limited, however, by inadequate controls,3 lack ofmasking,' and small sample size.79 In addition, most training regimens were conducted in hospital under medical supervision and may therefore have limited applicability in the community. The data have provided conflicting results with some trials failing to show improvement in respiratory muscle strength and endurance,'0 exercise capacity," 12 or functional capacity. '3 We have conducted a controlled trial of one type of respiratory muscle training in patients with moderate to severe chronic airflow limitation.
Methods

RECRUITMENT
The protocol was approved by the local institutional review board. Informed consent was obtained from all patients. Patients were recruited from a registry of over 1000 patients with chronic airflow limitation (defined as a best forced expired volume in one second (FEV,) of less than 70% of predicted and an FEV,/vital capacity (VC) ratio of less than 0-7). Patients were included if their exertional dyspnoea was severe enough to limit three important and frequent activities of daily living. Patients were excluded for the following reasons: (1) clinical instability as judged by change in respiratory medication in the month before entry or admission to hospital in the two months before the study; (2) inability to report on their day to day function because of cognitive, emotional, or linguistic problems; (3) objection to the patient's participation by their respiratory or family physician for whatever reason; (4) involvement in a respiratory muscle training regimen within the previous year.
STUDY DESIGN 
Outline
The study began with a run-in training period, after which the patients were randomized in sequence to one of four groups: (1) an experimental group who trained using six increasing levels of resistance (using an inspiratory resistance device, PFLEX) with nostrils occluded by a nose clip; (2) an experimental group who trained with increasing levels of resistance but without a nose clip; (3) a control group who trained using a nose clip and with PFLEX devices in which the diaphragm had been removed so that the device provided minimal resistance only; and (4) a control group who trained using minimal resistance and without a nose clip. Patients were followed at monthly intervals for six months and spirometry, measures of respiratory muscle strength and endurance, exercise capacity, and quality of life were carried out on each visit. Training sessions with a respiratory muscle training nurse continued for three months after randomization. Respiratory muscle strength Maximum inspiratory pressures were obtained as the best of three maximum efforts at functional residual capacity on a two channel recorder. The instantaneous peak pressure was recorded. A Marshall Town manometer was integrated into the circuit on the inspired side at the mouthpiece to check the pressures generated during the maximum pressure manoeuvre and during the session on the resistance circuit. Respiratory muscle endurance The patient sat in front of a respiratory muscle testing circuit and breathed through the inspiratory port. The circuit consisted of 1 5 In a secondary analysis, we included only patients in whom data from all six visits were available. Since the results of this secondary analysis did not differ substantively from the primary analysis, the results of the latter are presented.
Results
We identified 847 potentially eligible patients of whom 133 were enrolled. Major reasons for patients not enrolling included an objection from the consultant or family doctor and patient refusal. Forty patients dropped out during the run in period, in most cases because they became ill or found the commitment too great. Of the eleven patients who dropped out after randomisation, seven were allocated to active treatment and four to control. The reasons for dropping out varied. All four patients who found the commitment too great were in the active treatment group whereas all four who dropped out because of non-compliance were in the control group. The baseline characteristics of the 82 subjects who completed the trial are summarized in table 1 . Subjects who did and did not receive resistance training were comparable with respect to all major variables. Although the total number of intercurrent illnesses and changes in medication were greater in the control group (79 and 87 respectively) than in the resistance group (69 and 57) the number of illnesses associated with an increase in bronchodilators, steroids, or oxygen therapy were identical (30 in both groups). Of the admissions to hospital three of eleven in the control group were for respiratory disease, as were four of eleven in the resistance group.
Blinding of patients and research staff appears to have been effective since only on one occasion did the research assistant deduce, on the basis of comments from the patient, that allocation was to the control group and in fact the deduction was incorrect.
When asked, patients said they had missed no training sessions during the previous month on 41 % of occasions and on 59% of occasions they acknowledged missing some sessions-on 38% less than a third, on 50% one to two thirds, and on 12% more than two thirds. Noncompliance increased over the six months of the trial. During the first month patients said they had missed no training sessions during the previous month on 55% of occasions. By the sixth month the figure was 32%.
When patients were asked if any of the training sessions that they had undertaken were shorter than they should have been they said "no"' on 53% of occasions. When some shor- The most striking finding in our study was that training of the respiratory muscles was not achieved. One possibility is that respiratory muscle training regimens are in general ineffective. This would be true if, for instance, chronic airflow limitation imposes so severe an internal load on the respiratory muscles that they are fully trained for strengrh and endurance. If, however, respiratory muscles can be strengthened in patients with chronic airflow limitation, there must be other explanations for our negative results. Although patient nofi-compliance is a possible explanation, we believe that other explanations are more likely. It is possible that we selected patients less likely to respond to the intervention.'7 For instance, if enrolment had been restricted to patients with a low maximum inspiratory pressure, the results may have been positive. Given the heterogeneity of our population, and the lack of apparent trend in any subgroup, this seems unlikely.
An ability to tolerate increasing respiratory resistance can be achieved by changes in breathing pattern rather than by strengthening respiratory muscles, according to Belman and colleagues, who used the same PFLEX device as we used.'8 They found no improvement in resistance breathing performance or ventilatory muscle endurance with resistance breathing training with this device.
Findings in other studies can help decide the most likely explanation for our results. We have conducted a meta-analysis of all published and unpublished randomised trials of respiratory muscle training in patients with chronic airflow limitation,'9 meeting established criteria for a scientifically rigorous overview.'o Of the 13 studies included in the meta-analysis, 11 had studied the effects of resistance training and two the effect of volume training. Of the 11 which studied the effects of resistance training, the flow rates (and thus the resistance) generated during training were controlled by the investigators in four. Outcomes examined included maximum inspiratory pressure, maximum voluntary ventilation, respiratory muscle endurance, laboratory exercise capacity, functional exercise capacity, and functional status. For most outcomes, there were small non-significant trends in favour of respiratory muscle training.
In a secondary analysis we compared resis-tance studies in which the patient was required to target during training to achieve a specified flow rate with studies (such as the current one) in which there was no such requirement. There were substantial differences in effect size for respiratory muscle strength and endurance, functional exercise capacity, and functional capacity between the two types of studies; the effect sizes in the studies in which breathing pattern was controlled were clinically important. This difference in effect between studies in which breathing pattern was and was not controlled is weakened by the fact that it relies on differences between (rather than within) studies. 22 The magnitude of the differences was modest and statistically significant for respiratory muscle strength and functional capacity, but not for respiratory muscle endurance, laboratory exercise capacity, and functional exercise capacity.
We believe that the most likely explanation for our failure to improve respiratory muscle strength and endurance is that flow rates were not controlled. 
